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The kinesin superfamily proteins (KIFs) are motor
proteins that transport organelles and protein com-
plexes in a microtubule- and ATP-dependent man-
ner. We identified KIF26A as a new member of the
murine KIFs. KIF26A is a rather atypical member
as it lacks ATPase activity. Mice with a homozygous
deletion of Kif26a developed a megacolon with
enteric nerve hyperplasia. Kif26a/ enteric neurons
showed hypersensitivity for GDNF-Ret signaling,
and we find that KIF26A suppressed GDNF-Ret
signaling by direct binding and inhibition of Grb2,
an essential component of GDNF/Akt/ERK signaling.
We therefore propose that the unconventional kine-
sin KIF26A plays a key role in enteric nervous system
development by repressing a cell growth signaling
pathway.
INTRODUCTION
Thekinesin superfamily proteins (KIFs) havebeenshown to trans-
port various membranous organelles and protein complexes in
a microtubule- and ATP-dependent manner (Hirokawa and
Noda, 2008; Schliwa, 2002). A globular motor domain is present
in all KIFs, exhibiting a high degree of homology and containing
a microtubule-binding and an ATP-binding sequence. However,
outside the motor domain, each KIF possesses a unique
sequence. The diversity of these cargo-binding domains plays
a role in the mechanisms of action, as well as binding regulation
(Hirokawa and Takemura, 2005). A total of 45 murine and human
KIFs have been identified and classified into 14 large families—
termed kinesin 1 to 14 (Miki et al., 2001; Lawrence et al., 2004).
Here, we identified Kinesin superfamily protein 26A (KIF26A),
a new member of the KIFs belonging to the kinesin 11 subfamily
(Miki et al., 2001; Lawrence et al., 2004). KIF26A has a divergent
motor domain that exhibits microtubule-binding activity but
lacks ATPase activity, which indicates a function other than
cargo transport. To examine the role of KIF26A in vivo, we gener-
ated kif26a/ mice. Quite unexpectedly, we found that these
mice exhibited severe abnormalities in enteric nervous system
(ENS) development.802 Cell 139, 802–813, November 13, 2009 ª2009 Elsevier Inc.The ENS coordinates complex behaviors of the gastrointes-
tinal tract. ENS neurons and glial cells are organized into ganglia,
and these ganglia interconnect to form an enteric plexus. The
coordinated activity of multiple neurons residing in numerous
ganglia is required for normal ENS function. It has been estab-
lished that glial cell-derived neurotrophic factor (GDNF) signaling
regulates various aspects of ENS development through Ret
receptor tyrosine kinase, such as survival, proliferation, migra-
tion, and differentiation of enteric neurons (Heanue and Pachnis,
2007). Mutations in molecular components of GDNF-Ret
signaling result in ENS phenotypes in mutant mice, or in human
genetic disorders, such as Hirschsprung’s disease or multiple
endocrine neoplasia type 2b (MEN2B) (Cacalano et al., 1998;
Carney and Hayles, 1977; Moore et al., 1996; Pichel et al.,
1996; Sanchez et al., 1996; Schuchardt et al., 1994). However,
the mechanisms controlling GDNF-Ret signaling in ENS devel-
opment are incompletely understood.
Here, we show that disruption of the kif26a gene led to
increased numbers of enteric neurons, due to GDNF hyperres-
ponsiveness, which resulted in disturbed bowel movement regu-
lation and dilatation of the gastrointestinal tract. Mechanistically,
we found that KIF26A directly binds and inhibits Grb2/SHC
complex formation, thereby disrupting Ret tyrosine kinase acti-
vation and subsequent signaling of ERK1/2 and phosphatidyli-
nositol-3 kinase (PI3K) pathways. These results suggest a func-
tion for KIF26A as a negative regulator of GDNF-Ret signaling in
ENS development.
RESULTS
KIF26A: An Atypical Kinesin Superfamily Protein
Expressed in the ENS
On the basis of predicted sequences in Celera and public data-
bases, PCR amplification of full-length KIF26A frommouse brain
and testis libraries was performed to identify entire KIF26A
sequences. To date, KIF26A homologs have only been found
in vertebrates (Miki et al., 2001). KIF26A comprises 1881 amino
acids, and the predicted molecular weight is 196.3 kDa (NCBI
[http://www.ncbi.nlm.nih.gov/] accession number GQ489027).
The motor domain is localized to the N terminus, and the
coiled-coil domain is localized to the C terminus of the full
sequence (Figure 1A). Amino acid comparisons demonstrated
that motifs ‘‘EGYNG’’ and ‘‘IFAYGQT’’ (Miki et al., 2001), as
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Figure 1. KIF26A Structure and Expression
(A) The structure of KIF26A. The motor domain (362–726 aa) is located in the N terminus. The coiled-coil domain (1777–1809 aa) is located in the C terminus.
(B) Comparison of amino acid sequences in the motor domains.
(C) Microtubule binding assays. The first panel describes the method. Results from purified motor domains, detected by Coomassie Brilliant Blue (CBB) staining
(MD, second panel) and Flag-tagged full-length KIFs, and immunoblotted with an-anti-Flag antibody (third panel). Note that the motor domain and full-length
KIF26A are stably associated with microtubules, while KIF5A is dissociated from microtubules in an ATP-dependent manner. The fourth panel describes elution
of Flag-tagged KIF26A from microtubules via incubation with 1 M NaCl.
(D and E) Double-labeling study of kif26a in situ hybridization and PGP9.5 in colon sections at E12.5 and E14.5. Paraffin sections were hybridized to antisense and
sense riboprobes and detected by anti-digoxigenin (green) and anti-PGP9.5 (red) antibodies. Note that KIF26A is expressed in enteric ganglia and colocalizes
with anti-PGP9.5 antibody signals. Scale bars represent 10 mm.
(F and G) In situ hybridization using kif26a antisense riboprobes in WT (F) and kif26a/ (G) mouse colon at P12. The scale bar represents 5 mm.well as many amino acids essential for ATPase activity of KIFs,
were not conserved in the KIF26A motor domain (Figure 1B)
(Woehlke et al., 1997). To determine ATPase activity of KIF26A,
we performed an ATP-dependent microtubule-dissociating
assay using purified motor domains of KIF26A (Kondo et al.,
1994) (Figure 1C, first panel). In typical KIFs, such as KIF5A,
themotor domain utilizes energy from the ATPase cycle to disso-
ciate from microtubules (Nitta et al., 2004; Woehlke et al., 1997).
However, KIF26A binds continuously tomicrotubules (Figure 1C,
second panel). Similar results were obtained in the presentstudy using full-length KIF26A and KIF5A (Figure 1C, third panel).
Flag-tagged KIF26A was eluted when the pellet was incubated
with 1M NaCl, excluding the possibility that KIF26A formed
irreversible aggregates with microtubules (Figure 1C, fourth
panel). KIF26A properties are very similar to a rigor mutant of
KIF5 that lacks microtubule-dependent ATPase activity (Nakata
and Hirokawa, 1995). These results suggested that KIF26A binds
to microtubules but lacks microtubule-based motility.
To gain insight into the expression of kif26a gene, loxP-SA-
IRES-bgeo-loxP was inserted into kif26a locus by homologousCell 139, 802–813, November 13, 2009 ª2009 Elsevier Inc. 803
recombination (Figure S1A available online). Using
kif26a3loxP/3loxP mice, we conducted LacZ staining in the brain,
heart, lung, kidney, and colon at postnatal day 12 (P12). Strong
expression was detected in substantia nigra in brain and
enteric nervous system in colon at P12 (data not shown). To
confirm the expression in wild-type (WT) background, we
hybridized colon sections at embryonic day 12.5 (E12.5),
E14.5, and P12 with digoxigenin-labeled kif26a probes and
double-labeled them with anti-digoxigenin antibody and anti-
PGP9.5 antibody (neuronal marker) (Figures 1D, 1E, and
S1B). In colon sections at E12.5, E14.5, and P12, digoxige-
nin-positive signals colocalized well to PGP9.5-positive clusters
observed in muscular and submucosal layer, which indicated
exclusive ENS expression of the kif26a gene. Furthermore,
KIF26A was also detected in dorsal root ganglion and spinal
cord gray matter at E14.5 (Figures S1C and S1D). These data
suggest that kif26a gene is expressed in several neuronal pop-
ulations.
Myenteric Neuronal Hyperplasia in kif26a/ Mice
To gain insight into the function of KIF26A in vivo, we generated
kif26a/ mice (Figure S1A). Mating of kif26a+/ mice from a
C57BL/C background resulted in the expected Mendelian
frequency of 22.7% kif26a/ (25/110), 55.5% kif26a+/ (61/
110), and 21.8% kif26a+/+ (24/110) mice, as confirmed by
genomic PCR (Figure S1E, upper panels), RT-PCR with
KIF26A-specific primers (Figure S1E, lower panel), and western
blotting with anti-KIF26A antibody (Figure S1F). With kif26a/
mice used as a negative control, KIF26A expression in the ENS
was confirmed (Figures 1F and 1G).
kif26a/ mice exhibited growth retardation, became emaci-
ated, and died within 5 weeks of birth. The median and mean
life span of kif26a/ mice was 15 and 16 days, respectively
(range, 7–35 days) (Figure S1G). Macroscopic dissection re-
vealed that kif26a/mice suffered from megacolon (Figure 2A),
with dilation from the distal small intestine to the proximal colon.
Severe occlusion was observed in the distal colon (Figure 2B).
Considering expression patterns of kif26a in the developing
and adult ENS, these effects suggested that a defect in ENS
function might result in functional bowel obstruction. To assess
colon contractile responses in kif26a/ mice, we measured
contraction force in the distal colons. Colon contractions are
mediated by acetylcholine and can be induced by carbachol
(CCh), a long-acting acetylcholine agonist. Consistent with an
occluded distal colon, responses to CCh were prolonged in the
kif26a/ mouse colon, while the maximum contraction force
was not significantly different between genotypes (Figure 2C).
These data indicated that colon motility was not coordinated in
kif26a/ mice.
Histological examinations of the colon were performed in
kif26a/ mice. Hematoxylin and eosin staining revealed hyper-
trophy of enteric ganglia (hyperganglionosis) in the colon
(Figures 2D and 2E). The amount of protein gene product 9.5
(PGP9.5), a neuronal marker, was increased in the kif26a/
mouse colon, possibly because of hyperganglionosis (Figure 2F).
Because the myenteric plexus is composed of multiple types
of neurons, further histochemical analysis was performed with
two cell markers: acetylcholinesterase (AChE) and nicotinamide804 Cell 139, 802–813, November 13, 2009 ª2009 Elsevier Inc.adenine dinucleotide phosphate (NADPH) diaphorase. AChE-
positive cells and NADPH diaphorase-positive neurons are two
major cell populations residing in the myenteric plexus (Heanue
and Pachnis, 2007). The number of AChE- or NADPH diapho-
rase-positive cells, which were located in the red-colored region
shown in Figure 2G, was quantified and compared. Both cell
types were more abundant in the kif26a/ samples, compared
with the WT samples (Figures 2H–2K). Ganglia hypertrophy
was clearly observed under high magnification in the kif26a/
mouse distal colon (insets in Figure 2I). Differences between
the genotypes were statistically significant (Figures 2L and
2M), but not in the kif26a/ ileum (Figures S2A–S2F). The
number of AChE- or NADPH diaphorase-positive cells was
increased in the kif26a/ proximal colon (Figures S2G–S2L).
However, increased cell numbers in the kif26a/mouse bowels
were more prominent in the distal colon (54.6% increase in the
number of AChE-positive cells and 48.7% increase in the
number of NADPH diaphorase-positive cells), compared with
the proximal colon (26.8% increase in the number of AChE-posi-
tive cells and 22.6% increase in the number of NADPH diapho-
rase-positive cells).
ENS precursor proliferation was evaluated in kif26a/ mice.
Because colonization of ENS precursors in colon occurs
between E11.5 and E13.5 (Heanue and Pachnis, 2007), mitoti-
cally active cell populations were labeled in WT and kif26a/
embryonic bowels at E12.5 via a pulse injection of 5-bromodeox-
yuridine (BrdU). Tissue sections were prepared and double
stained with anti-BrdU and anti-PGP9.5 antibodies. The number
of BrdU-positive cells in the PGP9.5-positive cell population was
significantly increased in kif26a/ mice, compared with the WT
mice (Figures 2N–2P). These results indicated that the ENS
precursor proliferation was abnormally increased in kif26a/
mouse bowels.
Kif26a/ Mice Exhibit Defects in Myenteric Neurite
Outgrowth
WTenteric gangliawere typicallywell interconnectedbyAChE-or
NADPH diaphorase-positive fibers (arrows in Figures 3A and
S2M), whereas kif26a/ ganglia were less interconnected by
these fibers (Figures 3B and S2N). These results suggested that
kif26a/ ganglia failed to establish normal neuronal networks in
the colon. To examine possible morphological changes of
kif26a/ enteric neurons, we established dissociated primary
cultures (Lin et al., 2003). Enteric neurons dissociated from
muscular layer of P12 colons were fixed at 3 days in vitro and
double-labeled with anti-PGP9.5 and anti-smooth muscle
actin antibodies to discriminate neurons from muscle cells (Fig-
ures 3C–3F). As a result, neurite length was shown to be signifi-
cantly shorter in kif26a/ enteric neurons, and the difference
between WT and kif26a/ neurite length was statistically signifi-
cant (Figure3G,290±14.6mmand106±4.7mm,mean± standard
error of the mean [SEM], respectively; p < 0.001, t test). Because
results inFigure1Csuggested thatKIF26Aassociatedwithmicro-
tubules, microtubule stability was compared by immunocyto-
chemistry with anti-acetylated-tubulin and anti-tyrosinated-
tubulin antibodies. Results demonstrated reduced fluorescence
intensity of acetylated tubulin, but increased tyrosinated tubulin,
in the kif26a/ growth cones (Figures 3H–3P), which suggested
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Figure 2. Megacolon and Hyperganglionosis in
kif26a/ Mice
(A) The kif26a/ mouse megacolon.
(B) Dissection of the entire gastrointestinal tract from WT (left)
and kif26a/ mice (right). Note that the ileum, cecum, and
proximal colon are dilated in the kif26a/ mice, while the
distal colon is narrowed. st, stomach; ce, cecum.
(C) Left and middle panels: recording of colon contraction
force in response to 10 mM carbachol (CCh). Time periods
are indicated by A (5–10 min) and B (25–30 min) during CCh
treatment. Right panel: maximum contraction force during
periods A and B. Data are expressed as means ± SEM from
five WT and four kif26a/ colons (*p < 0.001; Student’s
t test). Calibration bars, 104 kgf (vertical) and 5 min (hori-
zontal).
(D and E) Hematoxylin and eosin staining of longitudinal
sections from P12 distal colons of WT (D) and kif26a/ (E)
mice. Myenteric (Auerbach) ganglia are bordered with a white
broken line. Note hyperganglionosis in kif26a/ mice. C,
circular muscle layer; L, longitudinal muscle layer. The scale
bar represents 50 mm.
(F) Expression of PGP9.5 in the mouse colon at P12.
(G) Quantification area of AChE-positive and NADPH diapho-
rase-positive cells in the gastrointestinal tract.
(H–K) Whole-mount en face views of AChE (H and I) and
NADPH diaphorase (J and K) staining of distal colons (P12).
Higher magnification views are shown in insets. Arrowheads
indicate cell bodies. Scale bars represent 25 mm.
(L and M) Statistical analysis revealed a 54.6% increase in the
number of AChE-positive cells (I) and a 48.7% increase in the
number of NADPH diaphorase-stained cells in the kif26a/
distal colon, compared with WT colon (P12). Data are
expressed as means ± standard deviation (SD) in six indepen-
dent experiments (*p < 0.001, Student’s t test).
(N and O) Hyperproliferation of ENS neuronal precursor in
kif26a/ mouse colon (E12.5). BrdU (green) and PGP9.5
(red) double labeling. The white and empty arrowheads indi-
cate BrdU-positive/PGP9.5-positive cells and BrdU-
negative/PGP-9.5-positive cells, respectively. The scale bar
represents 20 mm.
(P) Quantitative analysis of the number of proliferating precur-
sors in a 6 mm thick transverse section of the entire colon
length. The percentage of BrdU-positive/PGP9.5-positive
cells in all PGP9.5-positive cells is higher in kif26a/ mouse
colons than in WT controls (mean ± SD; WT, n = 3; kif26a/,
n = 3; n, number of embryos examined; *p < 0.01, Student’s
t test).Cell 139, 802–813, November 13, 2009 ª2009 Elsevier Inc. 805
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Figure 3. Defects in Neurite Outgrowth in kif26a/ Enteric Neurons
(A and B) AChE staining of longitudinal cryosections of distal colon (P12). Note that nerve networks between enteric ganglia decreased in kif26a/ mice (B)
compared with WT mice (arrows in A). The scale bar represents 50 mm.
(C and D) Representative enteric ganglia dissociated from P12 colon at 3 days in vitro. Neurons are labeled with a neuronal marker, PGP9.5 (green), and smooth
muscle is labeled with anti-smooth muscle actin antibody (red). Nerve fibers of kif26a/ ganglia (D) are shorter than those of WT ganglia (C). The scale bar repre-
sents 20 mm.
(E and F) Representative enteric neurons dissociated fromP12 colon labeled with PGP9.5 at 3 days in vitro. The neurites of a kif26a/ enteric neuron (F) aremuch
shorter than WT neurons (E). The scale bar represents 20 mm.
(G) Average neurite length. The length of the longest neurite in each cell was measured. Data are expressed as means ± SEM from six independent experiments.
More than 20 neurons were examined in each experiment (*p < 0.001; Student’s t test).
(H–O) Altered tubulin modifications in kif26a/ enteric neurons. Enteric neurons dissociated from P12 colon were stained with anti-acetylated tubulin (H and I)
and anti-tyrosinated tubulin (J and K) antibodies. Cells were counterstained with Phalloidin conjugated with Alexa568 (L–O). Note that the signal for acetylated
tubulin is reduced in the kif26a/ growth cone, while tyrosinated tubulin is increased.
(P) Statistical analysis of fluorescent signals for acetylated tubulin and tyrosinated tubulin. Bars represent the ratio between acetylated tubulin and actin in WT
(white) and kif26a/ (gray) and the ratio between tyrosinated tubulin and actin inWT (lined) and kif26a/ (black) mice. Data collected from 60 growth cones from
three independent pairs of WT and kif26a/ mice. Each value is expressed as mean ± SEM (*p < 0.01; Student’s t test).that microtubules were less stable in kif26a/ enteric neurons
than in WT neurons. Overexpression of KIF26A in COS cells
resulted in altered microtubule networks and increased microtu-
bule stability against nocodazole, a microtubule-depolymerizing
reagent (Figure S3), also suggesting that KIF26A exhibitedmicro-
tubule-stabilizing activity.
To assess the possibility that defects in other cell types
contributed to the development of megacolon, we compared
the morphology of other cells between genotypes (interstitial
cells of Cajal in the colon and smooth muscle cells in culture).
However, morphology of both cells, as well as Cajal cell density,
remained unchanged in kif26a/ mouse tissue or cultures (Fig-
ures S4A–S4E).806 Cell 139, 802–813, November 13, 2009 ª2009 Elsevier Inc.Kif26a/ Enteric Neurons Are Hypersensitive to GDNF
Previous studies have demonstrated that inactivation of GDNF-
Ret signaling results in aganglionosis of the myenteric plexus
(Cacalano et al., 1998; Moore et al., 1996; Pichel et al., 1996;
Sanchez et al., 1996; Schuchardt et al., 1994), whereas hyperac-
tivation of GDNF-Ret signaling induces hyperganglionosis of the
myenteric plexus (Hofstra et al., 1994; Taketomi et al., 2005;
Focke et al., 2001). Therefore, possible changes in GDNF-Ret
signaling were examined in the kif26a/ enteric neurons.
Because Ras/ERK1/2 and PI3K/Akt are crucial downstream
pathways (Segouffin-Cariou and Billaud, 2000; Focke et al.,
2001; Heanue and Pachnis, 2007), the activity of these
two signaling pathways was evaluated with two antibodies:
anti-phosphorylated ERK1/2 (pERK1/2) and anti-phosphory-
lated Akt (pAkt), respectively, as described previously (Taketomi
et al., 2005). Colon strips, prior to and after GDNF treatment,
were fixed, processed for subsequent immunohistochemistry,
and compared between the genotypes. Anti-bIII tubulin antibody
was simultaneously used as a neuronal marker. As shown in
Figures 4A and 4B, GDNF treatments abnormally increased
pERK1/2 and pAkt levels in kif26a/ enteric neurons, but
pERK1/2 and pAkt levels remained unchanged in muscle cells
(pERK1/2, Figure 4A; pAkt, Figure 4B). Cultured enteric neurons
were subsequently used to confirm GDNF-induced activation of
ERK1/2 and Akt in kif26a/ enteric neurons. After GDNF treat-
ment, the cultured kif26a/ neurons exhibited higher levels of
pERK1/2 and pAkt compared with WT neurons (Figures 4C–
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Figure 4. Phosphorylation of ERK and Akt
after GDNF Stimulation in Enteric Neurons
at P12
(A and B) Immunostaining of phosphorylated ERK
(A) and phosphorylated Akt (B) in longitudinal
paraffin sections of P12 colon. Anti-b-tubulin III
antibody (red) serves as a neuronal marker. Note
that fluorescent intensity of pERK and pAkt levels
is stronger in response to GDNF in enteric ganglia
of kif26a/ mice than in WT mice. Scale bars
represent 20 mm.
(C and D) ERK and Akt phosphorylation in cultured
enteric neurons derived from P12 colon after
GDNF stimulation. Cells with or without 5 min
treatment of GDNF immunostained with the
anti-pERK antibody (C) and cells with or without
30 min treatment of GDNF stained with anti-pAkt
antibody (D). Cells were counterstained with
anti-b-tubulin III antibody (red). Scale bars repre-
snet 20 mm.
(E and F) Statistical analysis of fluorescence inten-
sity of pERK (E) and pAkt (F) in cell bodies of
cultured cells. Data collected from 50 neurons
and derived from three pairs of WT and kif26a/
mice were used for each value and are expressed
as mean ± SD (*p < 0.001; one-way ANOVA).
4F). These results demonstrated that
GDNF-Ret signaling in kif26a/ enteric
neurons was hypersensitive to GDNF.
Overexpression of KIF26A
Suppressed GDNF-Ret signaling
GDNF binds to the heteromeric GFRa1-
Ret receptor complex, and the receptor
complex then binds to and phosphory-
lates SHC. Phosphorylated SHC con-
nects Ret to the cytoplasmic Grb2-Sos
and Grb2-Gab complex, resulting in acti-
vation of the Ras/ERK1/2 pathway and
PI3K/Akt, respectively (Besset et al.,
2000; Takahashi, 2001). The GDNF
receptor complex is endogenously
expressed in the neuroblastoma cell line
TGW, and GDNF treatment results in
phosphorylation of ERK1/2 and Akt (Ohiwa et al., 1997; Hayashi
et al., 2000). As we also find KIF26A expressed in TGW cells
(Figure 5A, upper panel), these cells were used to study the func-
tion of KIF26A. We generated a series of KIF26A deletion
mutants (Figure 5A, lower panel), and these constructs were
overexpressed in TGW cells. As a result, ERK1/2 and Akt phos-
phorylation, in response to GDNF, was significantly inhibited
when the full-length or tail domain of KIF26A (KIF26A-t; 751–
1881 aa) was overexpressed. In contrast, these effects were
not observed when the control vector or the tail-less construct
of KIF26A (Dtail; 1–730 aa) was overexpressed (Figure 5B).
These results led us to propose that a physical interaction might
exist between the KIF26A tail domain and molecular compo-
nents of the GDNF-Ret pathway. To test this directly, weCell 139, 802–813, November 13, 2009 ª2009 Elsevier Inc. 807
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Figure 5. Overexpression of KIF26A Inhibits the GDNF-Ret Signaling Pathway in Cells
(A) Upper panel: KIF26A expression in TGW cells. TGW cells were subjected to western blot analysis with an anti-KIF26A antibody. Lower panel: KIF26A
constructs used in this study.
(B) TGW cells were transfected with cDNA constructs and were subsequently serum starved overnight and subjected to western blot analysis prior to (GDNF)
and after (+GDNF) stimulation of GDNF for 1 hr with anti-ERK, anti-pERK, anti-Akt, and anti-pAkt antibodies. Left panel: a representative result from five inde-
pendent experiments. Right panel: quantification and statistical analysis. Relative band intensities compared with control samples were calculated. Data repre-
sent means ± SD from five independent experiments. *p < 0.01, Student’s t test, compared with control.
(C) Neuro2a cells were transfected with Flag-tagged KIF26A and were subsequently lysed and immunoprecipitated with normal mouse IgG beads (NMG) or anti-
Flag beads (Flag). The beads were subjected to western blot analysis with anti-Flag and anti-Grb2 antibodies.
(D) Immunoprecipitation experiments with a normal rabbit IgG (NRIg) or an anti-KIF26A antibody, followed by western blot analysis with anti-KIF26A and
anti-Grb2 antibodies.
(E) TGW cells were transfected with the indicated constructs and immunoprecipitated with anti-GFP beads. Beads were subjected to western blot analysis with
anti-GFP and anti-Flag antibodies. Left panel: Grb2 mutants used in this study. Right panel: a representative result of three independent western blot experi-
ments. *, IgG band.
(F) TGW cells were transfected with indicated cDNAs, treated with GDNF for 1 hr, and immunoprecipitated with normal mouse IgG beads (NMG) and anti-SHC
beads (SHC). Beads were subjected to western blot analysis with anti-SHC and anti-Grb2 antibodies. Left panel: a representative from five independent exper-
iments. Right panel: statistical analysis. Data represent means ± SD from five independent experiments. *p < 0.01, Student’s t test.
(G) Ret signaling complex in KIF26A-transfected TGW cells. TGW cells were transfected with full-length and Dtail KIF26A cDNA, serum starved overnight, and
lysed, and then immunoprecipitation was performed with an anti-Ret antibody. Left panel: a representative result of five independent experiments. Right panel:
statistical analysis. *p < 0.01, Student’s t test. Note that the amount of Sos1 and Gab1 binding to Ret was reduced when full-length KIF26A was transfected.preformed yeast two-hybrid assays and found that Grb2 specif-
ically bound to the KIF26A tail domain (Figure S5A). However,
Sos1, the Ret intracellular domain (639–1073 aa of Ret), SHC,
wild-type Ras (RasWT), active or inactive Ras (RasV12 or
RasN17), and Gab1 did not show binding. The KIF26A/Grb2808 Cell 139, 802–813, November 13, 2009 ª2009 Elsevier Inc.interaction was confirmed by immunoprecipitation of Flag-
tagged KIF26A or endogenous KIF26A with endogenous Grb2
(Figures 5C and 5D). Furthermore, we find that the SH2 domain,
but not the SH3 domain, of Grb2 was found to specifically asso-
ciate with KIF26A (Figure 5E). Previous studies have established
that the SH2 domain of Grb2 interacts with the phosphorylated
form of SHC adaptor protein via the phosphotyrosine binding
pocket (Chardin et al., 1995). When arginine (86 aa) in Grb2 is
substituted for lysine, that binding was abolished (Hidaka
et al., 1991). However, even this mutant could bind to KIF26A
(Figure S5B), suggesting that phosphotyrosine was not directly
involved in Grb2 binding to KIF26A. Further yeast two-hybrid
experiments showed that the 1429–1600 aa of KIF26A were
sufficient to bind to theGrb2 SH2 domain (Figure S5C). However,
previously knownmotifs for Grb2 SH2 binding were not detected
in this domain.
To test the possibility that KIF26A determined Grb2 localiza-
tion by binding to microtubules, we compared the cellular local-
ization of Grb2 between kif26a/ andWT enteric neurons. Grb2
localization in kif26a/ enteric neurons was not significantly
different from that in WT enteric neurons (Figures S5E–S5J).
We then tested whether the KIF26A and its deletion mutants
would interfere with Grb2-SHC complex formation. When full-
length or tail domain of KIF26A was overexpressed in TGW cells,
GDNF-induced formation of the SHC-Grb2 complex was signif-
icantly inhibited (Figure 5F). These results suggested that asso-
ciation of KIF26A with Grb2 sufficiently inhibited signaling, irre-
spective of KIF26A microtubule binding activity.
Subsequently, the effects of KIF26Aoverexpression onGDNF-
induced formation of Ret-Sos1 and Ret-Gab1 complexes were
analyzed, because the complex formation depends on Grb2
and these complexes are required to activate Ras-MAPK and
PI3K-Akt cascades, respectively (Besset et al., 2000). Our results
demonstrated that KIF26A overexpression inhibited formation of
these complexes, while the tail-less mutant did not (Figure 5G).
To monitor Ras activation, a downstream signal of this cascade,
we compared intracellular levels of GTP-binding Ras (GTP-Ras)
by using a glutathione S-transferase (GST) pulldown assay with
the Ras-binding domain (RBD) of Raf (Matsui et al., 2002). As
a result, increased GTP-Ras after GDNF treatment was signifi-
cantly inhibited by KIF26A overexpression (Figure S5D).
We also investigated the in vivo complex formation between
SHC and Grb2 in kif26a/ mice. In the presence and absence
of GDNF, SHC-Grb2 complex levels were below detection level
in lysates from the outer (muscular) colon layer of WT mice
(Figure 6A). However, in lysates from kif26a/ muscular layers,
SHCandGrb2 associationwas abnormally increased in the pres-
ence of GDNF (Figure 6A). Furthermore, Sos1 and Gab1 levels
associated with Ret were also significantly increased in lysates
from GDNF-treated kif26a/muscular layers (Figure 6B).
Finally, we analyzed whether KIF26A could have other effects
on the signaling pathway. Full-length KIF26A overexpression did
not alter cell surface levels of Ret in the TGW cells (Figure S5K).
In addition, when KIF26A was coexpressed with a constitutively
active form of Ras (RasV12), as well as a dominant negative
form of Ras (Ras N17), in TGW cells, the presence of KIF26A did
not affect ERK phosphorylation (Figure S5L). Moreover, KIF26A
did not affect Grb2 binding to Sos1 or Gab1 (Figure S5M).
KIF26A Knockdown Promotes GDNF-Ret Signaling
RNA interference (RNAi) experiments using targeted microRNA
(miRNA) were performed (Niwa et al., 2008). Two vectors
(miRNA912 and miRNA1104) were used to knock downKIF26A in TGW cells (Figure 6C). When KIF26A was knocked
down, levels of SHC-Grb2 complex, Ret-SOS complex, and
Ret-Gab1 complex increased in response to GDNF (Figures 6D
and 6E). GDNF-induced phosphorylation of ERK1/2 and Akt
significantly increased in KIF26A-knocked down cells (Fig-
ure 6F). In contrast, Ret levels on the cell surface remained
unchanged in KIF26A-knocked down cells (Figure S6A). Con-
versely, the amount of phosphorylated SHC increased in
KIF26A-knocked down cells (Figure S6B). This was most likely
because the amount of Grb2 associated with phosphorylated
SHC increased as a result of knocked down KIF26A, which
kept phosphorylated SHC away from phosphatases.
Together with results from the overexpression experiments
(Figure 5), these knockout and knockdown results clearly
demonstrated that KIF26A bound to Grb2 and inhibited GDNF-
induced formation of the SHC-Grb2 complex and suppressed
activation of ERK and Akt cascades (Figure 7).
DISCUSSION
KIF26A Is Essential for ENS Development
Kif26a/ mice exhibited a narrowed distal colon, which was
preceded by dilation of the proximal colon and ileum (Figures
2A and 2B). These abnormalities were macroscopically similar
to Hirschsprung’s disease in humans, or aganglionic megacolon
in a series of mutant mice with loss-of-function in GDNF-Ret
signaling (Heanue and Pachnis, 2007; Pichel et al., 1996;
Sanchez et al., 1996; Schuchardt et al., 1994).
Histopathological examination in the present study revealed
that the kif26a/mouse gastrointestinal system differed greatly
from Hirschsprung’s disease or related mutant mouse lines. In
contrast to aganglionosis or hypoganglionosis, which is typical
of megacolon disease, kif26a/ mice displayed hyperganglio-
nosis of enteric neurons in the colon (Figures 2H–2M and S2G–
S2L). This symptom was very similar to congenital megacolon
in the human, specifically MEN2B and neuronal intestinal
dysplasia (Athow et al., 1991; Carney and Hayles, 1977). ENS
precursor migration and proliferation are important steps in
ENS development (Heanue and Pachnis, 2007). If increased
ENS precursor migration were the cause of hyperganglionosis
in the distal colon, the number of ganglion in the proximal
part of bowel should decrease. In the present study, however,
the number of ganglia was not significantly changed in the
small intestine (Figures S2A–S2F), suggesting that increased
precursor migration was not the primary cause of hyperganglio-
nosis in the colon. Instead, increased ENS precursor cell prolifer-
ation was observed in the developing colon (Figures 2N–2P).
Cellular increase was more obvious in the narrow region of
the colon (Figures 2H–2M and S2G–S2L). In mutant animals,
increased contractility of the distal colon in response to carba-
chol correlated well with a narrowed distal bowel and dilated
proximal bowel. An explanation for apparent regional differences
in kif26a/ ENS structure and intestinal function was not clear
and requires additional investigation.
The Role of KIF26A as aMicrotubule-Associated Protein
Activation of Ret signaling generally results in neurite extension
(Fukuda et al., 2002; Takahashi, 2001). However, the kif26a/Cell 139, 802–813, November 13, 2009 ª2009 Elsevier Inc. 809
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Figure 6. GDNF-Ret Signaling Pathway was
Hypersensitive in the kif26a/ ENS and
KIF26A-Knockdown Neuroblastoma
(A) Immunoprecipitation was conducted using
a normal mouse IgG (NMG) and an anti-SHC
monoclonal antibody, followed by detection with
anti-SHC and anti-Grb2 polyclonal antibodies
prior to (GDNF) and after (+GDNF) stimulation
of GDNF for 1 hr in WT (+/+) and kif26a/ (/)
colons. SHC-Grb2 complex formation is signifi-
cantly augmented in GDNF-stimulated and
kif26a/ colons. Four independent experiments
were performed, and a representative image is
shown.
(B) Immunoprecipitation was conducted with an
anti-Ret antibody, followed by detection with
anti-Ret, anti-SOS, and anti-Gab1 antibodies prior
to (GDNF) and after (+GDNF) stimulation of
GDNF for 1 hr in WT (+/+) and kif26a/ (/)
colons. A representative image of three indepen-
dent experiments is shown.
(C) TGW neuroblastoma were transfected with
negative control microRNA (miRNA) vectors
(miRNANC) or miRNA vectors (miRNA912 and
miRNA1104), which were designed to knock
down human KIF26A. The samples were then incu-
bated for 3 days and subjected to western blot
analysis with anti-KIF26A and anti-KIF5 (clone
H2) antibodies. Note that KIF26A was below
detectable levels when miRNA912 or miRNA1104
was transfected.
(D) TGW cells were transfected with miRNA
vectors, and immunoprecipitation experiments
were conducted as described in Figure 6A.
Left panel: a representative from five experi-
ments. Right panel: quantification and statistical
analysis from five independent experiments.
Data represent means ± SD from five independent experiments. *p < 0.01, Student’s t test, compared with miRNANC.
(E) Immunoprecipitation experiments from KIF26A-knockdown TGW cells. Experiments were conducted as described in Figure 6B. A representative from three
independent experiments is shown.
(F) TGW cells were transfected with indicated vectors and subjected to western blot analysis with anti-ERK, anti-pERK, anti-Akt, and anti-pAkt antibodies. Left
panel: a representative from five experiments. Right panel: quantitative and statistical analysis from five independent experiments. The amount of pERK and pAkt
after GDNF stimulation is shown. Data represent means ± SD from five independent experiments. *p < 0.01, Student’s t test, compared with miRNANC.mouse ENS exhibited suppressed neurite outgrowth (Figures
3A–3G, S2M, and S2N), despite overactivation of ERK and
Akt (Figure 4). The question remained as to how the loss of810 Cell 139, 802–813, November 13, 2009 ª2009 Elsevier Inc.KIF26A resulted in shorter neurites. Our results demon-
strated that KIF26A bound to and stabilized microtubules
(Figures 1C and S3). Indeed, many other microtubule stabilizersGROWTH
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Figure 7. Schematic Model of KIF26A Involvement
in the Regulation of GDNF-Ret Signaling
In WT ENS, KIF26A binds to Grb2. This binding prevents Grb2
binding to SHC, which attenuates GDNF-Ret signaling. In the
kif26a/ENS, loss of KIF26A results in increased accessibility
of Grb2 to SHC, followed by overactivation of downstream
signal transduction and overgrowth of ENS.
(microtubule-associated proteins [MAPs]) have been shown to
control cellular morphology (Bouquet et al., 2004; Drabek
et al., 2006; Hirokawa, 1994; Kanai et al., 1989; Takemura
et al., 1992). In kif26a/ enteric neurons, the amount of acety-
lated tubulin was reduced, and tyrosinated tubulin was
increased (Figures 3H–3P). Because deacetylated and tyrosi-
natedmicrotubules represent unstable microtubule populations,
results suggested that microtubules are less stable in kif26a/
growth cones compared with WT growth cones. Similar pheno-
types have been reported in MAP-knockout cells (Bouquet et al.,
2004; Drabek et al., 2006). Results from the present study sug-
gested that unstable microtubules, because of KIF26A loss,
masked the effect of an overactivated Ret signaling pathway in
promoting neurite elongation, and resulted in shorter axons in
enteric neurons.
KIF26A Role in Cellular Signaling
Recent studies have focused on the ability of KIFs and MAPs to
control cell signaling. For example, KIF4 has been shown to
regulate PARP-1-mediated signal transduction, thereby control-
ling activity-dependent neuronal survival and death (Midorikawa
et al., 2006). This regulation is independent of motor function.
MAP2 has been shown to control cellular signaling, as well as
microtubule stability (Harada et al., 2002). In the present study,
abnormal hyperresponsiveness of GDNF-Ret signaling and
overactivation of ERK and Akt cascades were observed in the
kif26a/ mice. Further experiments revealed that KIF26A over-
expression suppressed GDNF-Ret signaling (Figure 5). Previous
studies have demonstrated that sprouty2 inhibits the GDNF-Ret
pathway during ENS development (Taketomi et al., 2005). The
loss of sprouty2 in mice leads to enteric neuronal hyperplasia,
and sprouty2 intercepts GDNF-Ret signaling through Grb2
(Hanafusa et al., 2002). Although KIF26A also binds to Grb2,
sprouty2 did not exhibit any structural similarity to KIF26A.
Therefore, we assume that during ENS development in vivo,
two different mechanisms negatively regulate GDNF-Ret sig-
naling via Grb2. Because KIF26A was bound to microtubules
(Figure 1C), it is possible that KIF26A inhibited signaling and
blocked Grb2 access to membrane receptors by tethering it to
microtubule polymers. The other possibility is that KIF26A tail
domain binding to Grb2 influenced interactions between Grb2
and SHC (Figure 7). Because the KIF26A tail domain was able
to sufficiently inhibit GDNF/Ret signaling (Figure 5), the latter
possibility is preferred. Nevertheless, the possibility that micro-
tubules played a role in the observed inhibitory effects of endog-
enous KIF26A cannot be completely dismissed. Future gene
replacement studies will be needed to fully answer this question.
Our findings showed that the 1429–1600 aa region of KIF26A
associated with the SH2 domain of Grb2 (Figure S5C). Other
studies have shown that the phosphotyrosine-binding pocket
of the SH2 domain binds to the YXNX motif in a tyrosine
kinase-dependent manner (Hidaka et al., 1991; Chardin et al.,
1995; Hanafusa et al., 2002). However, the results suggest that
phosphotyrosine is not needed in KIF26A-Grb2 binding,
because (1) the YXNX motif does not exist in the 1429–1600 aa
region of KIF26A, (2) the association between KIF26A and
Grb2 was observed in yeast, which do not contain tyrosine
kinases (Figures S5A and S5C), and (3) the R86K mutant, whichdoes not recognize phosphotyrosine, could still bind to KIF26A
(Figure S5B). This feature was clearly different from sprouty2,
which requires phosphotyrosine to associate with Grb2 (Hana-
fusa et al., 2002). In our analysis, we did not detect any known
motifs that bind to SH2 domain in the 1429–1600 aa of KIF26A.
Therefore, we conclude that KIF26A associated with the SH2
domain of Grb2 through a novel binding mechanism. Further
studies are needed to determine how this binding is regulated
and how the association of Grb2 with SHC is inhibited by
KIF26A. Because KIF26A bound to the Grb2 SH2 domain, which
is an interface that associates with SHC, it is possible that
binding of KIF26A to the SH2 domain directly inhibited the asso-
ciation in a competitive manner. It is also possible that KIF26A
indirectly inhibited the association by altering Grb2 conforma-
tion. Biochemical assays with SHC-derived phosphotyrosine-
containing peptide (Hanafusa et al., 2002), as well as structural
analysis with X-ray crystallography or nuclear magnetic reso-
nance, would help to answer these questions.
In conclusion, the present study established a relationship for
the novel kinesin superfamily protein 26A and GDNF-Ret
signaling. Further studies of KIF26A will reveal the molecular
mechanisms underlying ENS development.
EXPERIMENTAL PROCEDURES
Cloning and Gene Targeting
With predicted sequences of KIF26A in Celera and NCBI databases, KIF26A
encoding complementary DNA (cDNA) was amplified from mouse brain and
testis cDNA libraries by PCR. Homologous recombination of embryonic
stem cells (ESCs) was conducted by electroporation of a targeting vector
(Figure S1). Chimeric mice were generated by injection of ESCs into C57Bl/
6J mouse blastocysts. kif26a+/3loxp mice were generated by breeding of
chimeric mice with C57Bl/6J mice. kif26a+/3loxp mice were bred with CAG-
Cre transgenic mice (kindly provided from J. Miyazaki) in order to generate
kif26a+/ mice. All procedures involving animals were approved by School of
Medicine, University of Tokyo, and conformed to the relevant regulatory
standards.
Cell Cultures
COS-7, TGW, and Neuro2a cells were obtained from Health Sciences
Research Resources Bank. These cells were cultured in DMEM (Sigma) sup-
plemented with 10% FCS. For primary culture of enteric cells, strips of longi-
tudinal smooth muscle layers dissociated from P12 mice colon were resected,
washed and cut into 5 mm long pieces, and incubated at 37C in dissociation
buffer (Ca2+- and Mg2+-free Hank’s balanced salt solution [HBSS], 1.5 mg/ml
collagenase [GIBCO] and 1.3 mg/ml trypsin). Dissociated cells were main-
tained in Neurobasal A (GIBCO) containing 10% FCS, 0.5 mM L-glutamine
(Sigma G7513), 100 mg/ml streptomycin sulfate, and 100 units/ml penicillin
G sodium (GIBCO) as previously described (Lin et al., 2003).
TGW cells were transfected with Nucleofector ver.1 (Amaxa). Neuro2a and
COS-7 cells were transfected with Lipofectamine 2000 (Invitrogen).
Microtubule Binding Assay
pCMVTag4B-KIF26A or pCMVTag4B-KIF5A were transfected into COS-7
cells. Seventy-two hours later, cells were lysed with PHEM buffer (50 mM
Pipes, 50 mM HEPES [pH 7.2], 10 mM EGTA, 5 mM MgCl2) containing 1%
Triton X-100 and complete protease inhibitor (Roche), followed by centrifuga-
tion at 100,000 3 g for 30 min at 4C. For the purified motor domain (MD),
samples were prepared (described in the ‘‘Expression and Purification of
Recombinant Proteins’’ section of the Supplemental Experimental Proce-
dures) and centrifuged at 100,000 3 g for 30 min at 4C. The samples were
then supplemented with 0.2 mg/ml of a taxol-stabilized microtubule solution,
which was purified from porcine brain as previously described (Kondo et al.,Cell 139, 802–813, November 13, 2009 ª2009 Elsevier Inc. 811
1994). The mixture was incubated at room temperature for 30 min in the pres-
ence of 20 mM taxol and 2mMAMP-PNP and centrifuged at 100,0003 g for 15
min at 20C. The supernatant (S1) was stored at 4C for further analysis. The
pellet (P1) was resuspended with PHEM containing 20 mM taxol and 10 mM
[Mg2+] ATP, followed by incubation at room temperature for 30 min and centri-
fugation at 100,0003 g for 15 min at 20C. Together with S1 and P1 fractions,
the supernatant (S2) and pellet (P2) were subjected to SDS-PAGE or western
blot analysis. For release of Flag-KIF26A from the P2 fraction, the pellet was
resuspended with PHEM containing 20 mM taxol and 1 M NaCl at room
temperature for 30 min and centrifuged at 100,000 3 g for 15 min at 20C.
Measurement of Colon Contraction Force
Colon contraction force was measured at room temperature with a spring
balance connected to a computer. The datawas analyzed with pCLAMP9 soft-
ware (Axon Instruments).
Immunohistochemistry, In Situ Hybridization,
and Immunocytochemistry
Immunohistochemical detection of pERK1/2 and pAkt was described before
(Taketomi et al., 2005). For in situ hybridization, mice were sacrificed and
colons were dissected. Colons were fixed overnight in 4% paraformaldehyde
(PFA) in phosphate-buffered saline (PBS). The tissues were dehydrated in
ethanol, embedded in Paraplast (Oxford Labware), and sectioned serially
into 7 mm thick sections with a Microtom (HM355; Rotary Micotome). The
sections were deparaffinized and washed with 53 SSC for 15 min at room
temperature and hybridized with digocygenin-labeled probes. For immunocy-
tochemistry, cultured cells were washed oncewith HBSS and fixed in 4%PFA.
Cells were blocked with PBS supplemented with 1% bovine serum albumin for
20 min, and primary antibodies were incubated for overnight.
For signal detection in immunohistochemistry, in situ hybridization, and
immunocytochemistry, Alexa-labeled antibodies (Molecular probes) were
used. Stained colon strips and cell cultures were photographed and observed
with a confocal laser-scanning microscope (LSM510; ZEISS). Quantitative
fluorescent microscopy was conducted as described (Niwa et al., 2008).
Binding Assays, Cell Surface Labeling, and Phosphorylation
Analysis
Immunoprecipitation and GST pull down were conducted as described
(Matsui et al., 2002; Niwa et al., 2008). Yeast two-hybrid assays were con-
ducted with the Matchmaker version 3 kit (Clontech). For cell surface labeling,
cells had been incubated for 72 hr after transfection. The Cell Surface Protein
Isolation Kit (PIERCE) was used as described in the manufacturer’s manual.
For analysis of Erk and Akt phosphorylation, samples were homogenized on
ice in NP40 buffer (10 mM HEPES [pH 7.2], 150 mM NaCl, 1% NP40) supple-
mented with complete protease inhibitor and PhosSTOP phosphatase inhib-
itor (Roche). Samples were subjected to western blot analysis with anti-ERK,
anti-pERK, anti-Akt, and anti-pAkt antibodies. The sample amount was cali-
brated based on ERK and Akt band intensity.
RNAi
The BLOCK-iT PolII miR RNAi Expression Kit (Invitrogen) was used as
described in the manual. Four miRNAs were designed with BLOCK-iT RNAi
Designer (https://rnaidesigner.invitrogen.com/rnaiexpress/#/).
ACCESSION NUMBERS
Sequence data of KIF26A is available via the NCBI with accession number
GQ489027.
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